Adult Nursing Care Unit 11 Review: Hematological Disorders

Key Concepts in Hematology

• Hematopoiesis involves the formation and development of blood cells in the bone marrow
  • Includes erythropoiesis (red blood cell production), leukopoiesis (white blood cell production), and thrombopoiesis (platelet production)
• Hemostasis maintains blood in a fluid state within the vessels and forms clots to prevent blood loss during injury
  • Involves platelets, coagulation factors, and fibrinolytic system
• Anemia characterized by a decreased number of red blood cells or hemoglobin, leading to reduced oxygen-carrying capacity
  • Can be caused by blood loss, decreased production, or increased destruction of red blood cells (hemolysis)
• Leukocytes play a crucial role in the body's immune response and defense against infections
  • Includes neutrophils, lymphocytes, monocytes, eosinophils, and basophils
• Thrombocytopenia refers to a low platelet count, which can lead to increased risk of bleeding
  • Can be caused by decreased production, increased destruction, or sequestration of platelets
• Coagulation disorders disrupt the balance between clotting and bleeding
  • Includes hemophilia (deficiency of clotting factors) and thrombophilia (increased tendency to form clots)

Common Hematological Disorders

• Iron-deficiency anemia most common type of anemia, caused by insufficient iron intake or absorption
  • Symptoms include fatigue, pallor, and shortness of breath
• Sickle cell disease inherited disorder characterized by abnormal hemoglobin that causes red blood cells to become sickle-shaped and fragile
  • Leads to chronic anemia, pain crises, and organ damage
• Thalassemia group of inherited disorders that affect hemoglobin production, leading to anemia and other complications
  • Includes alpha-thalassemia and beta-thalassemia
• Leukemia cancer of the blood cells, characterized by the uncontrolled growth of abnormal white blood cells
  • Can be acute (rapidly progressing) or chronic (slowly progressing)
• Lymphoma cancer that originates in the lymphatic system, affecting lymphocytes
  • Includes Hodgkin's lymphoma and non-Hodgkin's lymphoma
• Myeloma cancer of plasma cells, which are responsible for producing antibodies
  • Leads to bone destruction, anemia, and kidney problems
• Hemophilia inherited bleeding disorder caused by a deficiency in specific clotting factors
  • Most common types are hemophilia A (factor VIII deficiency) and hemophilia B (factor IX deficiency)

Diagnostic Tests and Procedures

• Complete blood count (CBC) measures the number and characteristics of red blood cells, white blood cells, and platelets
  • Provides information about anemia, infections, and blood disorders
• Peripheral blood smear examination of a thin layer of blood under a microscope to assess the appearance and morphology of blood cells
  • Helps identify abnormalities in cell shape, size, or number
• Bone marrow aspiration and biopsy involve obtaining a sample of bone marrow for microscopic examination
  • Used to diagnose blood cancers, assess response to treatment, and evaluate abnormalities in blood cell production
• Coagulation tests assess the functioning of the clotting system
  • Includes prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen levels
• Flow cytometry analyzes the characteristics of individual cells using laser technology
  • Used to diagnose and classify leukemias and lymphomas based on cell surface markers
• Genetic testing identifies specific gene mutations or chromosomal abnormalities associated with inherited blood disorders
  • Includes tests for sickle cell disease, thalassemia, and hemophilia

Treatment Approaches

• Blood transfusions involve the administration of whole blood or specific blood components (red blood cells, platelets, or plasma) to replace missing or defective elements
  • Used to treat anemia, thrombocytopenia, and bleeding disorders
• Iron supplementation oral or intravenous administration of iron to correct iron-deficiency anemia
  • Helps restore hemoglobin levels and alleviate symptoms
• Erythropoiesis-stimulating agents (ESAs) medications that stimulate the production of red blood cells in the bone marrow
  • Used to treat anemia associated with chronic kidney disease and chemotherapy
• Chemotherapy uses cytotoxic drugs to kill rapidly dividing cancer cells
  • Used to treat leukemia, lymphoma, and myeloma
• Targeted therapy uses drugs that specifically target abnormal proteins or genetic changes in cancer cells
  • Examples include tyrosine kinase inhibitors (imatinib) and monoclonal antibodies (rituximab)
• Stem cell transplantation involves infusing healthy stem cells to replace damaged or diseased bone marrow
  • Can be autologous (using patient's own stem cells) or allogeneic (using donor stem cells)
• Gene therapy involves introducing functional copies of defective genes into patient's cells to correct genetic disorders
  • Currently being researched for conditions like sickle cell disease and hemophilia

Nursing Assessment and Interventions

• Assess for signs and symptoms of anemia, such as pallor, fatigue, shortness of breath, and tachycardia
  • Monitor hemoglobin and hematocrit levels and administer blood transfusions as ordered
• Monitor for signs of bleeding, including petechiae, ecchymoses, and prolonged bleeding from wounds
  • Assess platelet count and coagulation test results and administer platelet transfusions or clotting factor concentrates as needed
• Administer medications as prescribed, such as iron supplements, ESAs, chemotherapy, and targeted therapies
  • Monitor for side effects and adverse reactions and educate patients about proper administration and precautions
• Implement infection control measures to prevent infections in patients with compromised immune systems
  • Encourage good hand hygiene, use protective equipment, and monitor for signs of infection
• Provide pain management for patients experiencing pain related to their hematological disorder or treatment
  • Use pharmacological and non-pharmacological interventions and assess pain levels regularly
• Offer emotional support and counseling to patients and their families coping with chronic or life-threatening blood disorders
  • Connect them with support groups and resources and facilitate open communication with the healthcare team

Patient Education and Self-Management

• Teach patients about their specific hematological disorder, including causes, symptoms, and potential complications
  • Provide written materials and resources for further learning
• Educate patients about the importance of adhering to their prescribed treatment plan, including medications, lifestyle modifications, and follow-up appointments
  • Explain the purpose and potential side effects of each treatment
• Encourage patients to maintain a healthy lifestyle, including a balanced diet, regular exercise, and stress management
  • Provide guidance on specific dietary requirements, such as iron-rich foods for iron-deficiency anemia
• Teach patients how to recognize signs and symptoms of complications or worsening of their condition
  • Provide clear instructions on when to seek medical attention
• Educate patients about the importance of infection prevention, especially if they have a compromised immune system
  • Teach proper hand hygiene, avoidance of sick contacts, and prompt reporting of fever or signs of infection
• Provide patients with information about support groups, community resources, and financial assistance programs
  • Encourage them to connect with others who have similar conditions and to advocate for their healthcare needs

Complications and Emergency Situations

• Severe anemia can lead to heart failure, angina, or myocardial infarction due to the increased workload on the heart
  • Requires prompt recognition and treatment with blood transfusions and oxygen therapy
• Acute chest syndrome life-threatening complication of sickle cell disease characterized by chest pain, fever, and respiratory distress
  • Requires immediate treatment with oxygen, pain management, and exchange transfusions
• Disseminated intravascular coagulation (DIC) systemic activation of the coagulation cascade, leading to widespread clotting and bleeding
  • Can be triggered by sepsis, trauma, or certain cancers and requires intensive supportive care
• Tumor lysis syndrome occurs when cancer cells break down rapidly, releasing large amounts of potassium, phosphate, and uric acid into the bloodstream
  • Can lead to kidney failure and cardiac arrhythmias and requires close monitoring and aggressive hydration
• Hyperviscosity syndrome occurs when the blood becomes too thick due to an excess of proteins or cells, leading to impaired blood flow and organ damage
  • Requires urgent treatment with plasmapheresis to remove the excess substances from the blood
• Neutropenic fever occurs when a patient with a low neutrophil count develops a fever, indicating a potentially serious infection
  • Requires prompt evaluation and initiation of broad-spectrum antibiotics to prevent sepsis

Emerging Therapies and Research

• CAR T-cell therapy involves genetically modifying a patient's T-cells to target and destroy cancer cells
  • Shows promise in treating certain types of leukemia and lymphoma that have not responded to traditional therapies
• Gene editing techniques, such as CRISPR-Cas9, are being explored to correct genetic mutations responsible for blood disorders like sickle cell disease and thalassemia
  • Involves precise modification of the patient's DNA to restore normal gene function
• Novel targeted therapies are being developed to attack specific molecular pathways or mutations in blood cancers
  • Examples include BCL-2 inhibitors (venetoclax) for chronic lymphocytic leukemia and IDH inhibitors (ivosidenib) for acute myeloid leukemia
• Immunotherapy harnesses the power of the patient's immune system to fight blood cancers
  • Includes checkpoint inhibitors, bispecific antibodies, and cancer vaccines
• Personalized medicine involves tailoring treatment based on a patient's genetic profile, molecular characteristics of their disease, and response to therapy
  • Aims to optimize outcomes and minimize side effects by selecting the most appropriate treatment for each individual
• Ongoing clinical trials are investigating new drugs, combinations of therapies, and innovative approaches to managing hematological disorders
  • Participation in clinical trials offers patients access to potentially groundbreaking treatments and contributes to the advancement of medical knowledge